Business Context and Reporting Period
This Form 8-K was filed by BioRestorative Therapies, Inc. on November 17, 2017. The report details a material definitive agreement entered into on the same date regarding the extension of debt obligations and the modification of warrant exercise prices.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or liquidity metrics. It specifically addresses the following debt and equity instruments:
- Promissory Note 1: Principal amount of $175,000 held by John M. Desmarais (Director and principal stockholder).
- Promissory Note 2: Principal amount of $500,000 held by a trust for the benefit of Mr. Desmarais' immediate family.
- Warrant Modifications: Reduction of exercise prices for warrants held by Mr. Desmarais covering an aggregate of 1,219,444 shares of common stock.
Material Changes Versus Prior Period
The primary material change reported is the extension of the maturity dates for two promissory notes:
- The due date for the $175,000 note was extended from December 1, 2017, to December 1, 2018.
- The due date for the $500,000 note was extended from December 1, 2017, to December 1, 2018.
Concurrently, the exercise prices for specific warrants were reduced:
- 775,000 shares: Exercise price reduced from $5.00 to $4.00 per share.
- 444,444 shares: Exercise price reduced from $4.50 to $4.00 per share.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the implications of the debt extension. The agreement was made in consideration for the note extensions, indicating a restructuring of short-term liabilities with a related party.
Investor Verification Checklist
- Verify the total outstanding debt obligations of the company beyond the $675,000 mentioned in this filing.
- Confirm the interest rates applicable to the extended promissory notes.
- Assess the dilution impact of the warrant price reductions on existing shareholders.
- Review the company's cash position to understand the necessity of extending debt due dates.